HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quinn, A. Articles by Sercarz, E. E. Search for Related Content PubMed PubMed Citation Articles by Quinn, A. Articles by Sercarz, E. E.

MHC Class I-Restricted Determinants on the Glutamic Acid Decarboxylase 65 Molecule Induce Spontaneous CTL Activity¹

Anthony Quinn^*, Marcia F. McInerney and Eli E. Sercarz^2,*

^* Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121; and University of Toledo, College of Pharmacy, Toledo, OH 43606

CD4⁺ T cell responses to glutamic acid decarboxylase (GAD65) spontaneously arise in nonobese diabetic (NOD) mice before the onset of insulin-dependent diabetes mellitus (IDDM) and may be critical to the pathogenic process. However, since both CD4⁺ and CD8⁺ T cells are involved in autoimmune diabetes, we sought to determine whether GAD65-specific CD8⁺ T cells were also present in prediabetic NOD mice and contribute to IDDM. To refine the analysis, putative K^d-binding determinants that were proximal to previously described dominant Th determinants (206–220 and 524–543) were examined for their ability to elicit cytolytic activity in young NOD mice. Naive NOD spleen cells stimulated with GAD65 peptides 206–214 (p206) and 546–554 (p546) produced IFN- and showed Ag-specific CTL responses against targets pulsed with homologous peptide. Conversely, several GAD peptides distal to the Th determinants, and control K^d-binding peptides did not induce similar responses. Spontaneous CTL responses to p206 and p546 were mediated by CD8⁺ T cells that are capable of lysing GAD65-expressing target cells, and p546-specific T cells transferred insulitis to NOD.scid mice. Young NOD mice pretreated with p206 and p546 showed reduced CTL responses to homologous peptides and a delay in the onset of IDDM. Thus, MHC class I-restricted responses to GAD65 may provide an inflammatory focus for the generation of islet-specific pathogenesis and cell destruction. This report reveals a potential therapeutic role for MHC class I-restricted peptides in treating autoimmune disease and revisits the notion that the CD4- and CD8-inducing determinants on some molecules may benefit from a proximal relationship.

This article has been cited by other articles:

				A. Quinn, M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, and E. Sercarz T cells to a dominant epitope of GAD65 express a public CDR3 motif Int. Immunol., June 1, 2006; 18(6): 967 - 979. [Abstract] [Full Text] [PDF]

				C. P. Wong, L. Li, J. A. Frelinger, and R. Tisch Early Autoimmune Destruction of Islet Grafts Is Associated with a Restricted Repertoire of IGRP-Specific CD8+ T Cells in Diabetic Nonobese Diabetic Mice J. Immunol., February 1, 2006; 176(3): 1637 - 1644. [Abstract] [Full Text] [PDF]

				G. Han, Y. Li, J. Wang, R. Wang, G. Chen, L. Song, R. Xu, M. Yu, X. Wu, J. Qian, et al. Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500-585 J. Immunol., April 15, 2005; 174(8): 4516 - 4524. [Abstract] [Full Text] [PDF]

				R. Kennedy, A. H. Undale, W. C. Kieper, M. S. Block, L. R. Pease, and E. Celis Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses J. Immunol., April 1, 2005; 174(7): 3967 - 3977. [Abstract] [Full Text] [PDF]

				S. M. Lieberman, T. Takaki, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo Individual Nonobese Diabetic Mice Exhibit Unique Patterns of CD8+ T Cell Reactivity to Three Islet Antigens, Including the Newly Identified Widely Expressed Dystrophia Myotonica Kinase J. Immunol., December 1, 2004; 173(11): 6727 - 6734. [Abstract] [Full Text] [PDF]

				T. Takaki, S. M. Lieberman, T. M. Holl, B. Han, P. Santamaria, D. V. Serreze, and T. P. DiLorenzo Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4 J. Immunol., August 15, 2004; 173(4): 2530 - 2541. [Abstract] [Full Text] [PDF]

				A. Margalit, S. Fishman, D. Berko, J. Engberg, and G. Gross Chimeric {beta}2 microglobulin/CD3{zeta} polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8+ T cells Int. Immunol., November 1, 2003; 15(11): 1379 - 1387. [Abstract] [Full Text] [PDF]

				E. Anastasi, A. F. Campese, D. Bellavia, A. Bulotta, A. Balestri, M. Pascucci, S. Checquolo, R. Gradini, U. Lendahl, L. Frati, et al. Expression of Activated Notch3 in Transgenic Mice Enhances Generation of T Regulatory Cells and Protects against Experimental Autoimmune Diabetes J. Immunol., November 1, 2003; 171(9): 4504 - 4511. [Abstract] [Full Text] [PDF]

				E. Jaeckel, L. Klein, N. Martin-Orozco, and H. von Boehmer Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase J. Exp. Med., June 16, 2003; 197(12): 1635 - 1644. [Abstract] [Full Text] [PDF]

				C. Gianfrani, R. Troncone, P. Mugione, E. Cosentini, M. De Pascale, C. Faruolo, S. Senger, G. Terrazzano, S. Southwood, S. Auricchio, et al. Celiac Disease Association with CD8+ T Cell Responses: Identification of a Novel Gliadin-Derived HLA-A2-Restricted Epitope J. Immunol., March 1, 2003; 170(5): 2719 - 2726. [Abstract] [Full Text] [PDF]

				G. Rajagopalan, Y. C. Kudva, R. A. Flavell, and C. S. David Accelerated Diabetes in Rat Insulin Promoter-Tumor Necrosis Factor-{alpha} Transgenic Nonobese Diabetic Mice Lacking Major Histocompatibility Class II Molecules Diabetes, February 1, 2003; 52(2): 342 - 347. [Abstract] [Full Text] [PDF]